These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 16931208)

  • 1. Cardiovascular biomarkers in CKD: pathophysiology and implications for clinical management of cardiac disease.
    Roberts MA; Hare DL; Ratnaike S; Ierino FL
    Am J Kidney Dis; 2006 Sep; 48(3):341-60. PubMed ID: 16931208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease.
    Kendrick J; Chonchol MB
    Nat Clin Pract Nephrol; 2008 Dec; 4(12):672-81. PubMed ID: 18825155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Chronic kidney disease (CKD) as an independent risk factor for cardiovascular disease (CVD)].
    Minami J; Ishimitsu T; Sudo Y; Matsuoka H
    Nihon Rinsho; 2008 Sep; 66(9):1657-63. PubMed ID: 18788391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
    Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
    J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients.
    Fernandez-Fresnedo G; Rodrigo E; de Francisco AL; de Castro SS; Castañeda O; Arias M
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S246-9. PubMed ID: 17130269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting the endothelium: a new focus for management of chronic kidney disease.
    Diaz-Buxo JA; Woods HF
    Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease: a risk factor for cardiovascular disease.
    Wali RK; Henrich WL
    Cardiol Clin; 2005 Aug; 23(3):343-62. PubMed ID: 16084283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial dysfunction links cardiovascular disease to pediatric chronic kidney disease: the role of nitric oxide deficiency.
    Tain YL
    Acta Paediatr Taiwan; 2007; 48(5):246-50. PubMed ID: 18254572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk among adults with chronic kidney disease, with or without prior myocardial infarction.
    Wattanakit K; Coresh J; Muntner P; Marsh J; Folsom AR
    J Am Coll Cardiol; 2006 Sep; 48(6):1183-9. PubMed ID: 16979003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease and chronic kidney disease: insights and an update.
    Best PJ; Reddan DN; Berger PB; Szczech LA; McCullough PA; Califf RM
    Am Heart J; 2004 Aug; 148(2):230-42. PubMed ID: 15308992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of inflammation on epigenetic DNA methylation - a novel risk factor for cardiovascular disease?
    Stenvinkel P; Karimi M; Johansson S; Axelsson J; Suliman M; Lindholm B; Heimbürger O; Barany P; Alvestrand A; Nordfors L; Qureshi AR; Ekström TJ; Schalling M
    J Intern Med; 2007 May; 261(5):488-99. PubMed ID: 17444888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated serum levels of S-adenosylhomocysteine, but not homocysteine, are associated with cardiovascular disease in stage 5 chronic kidney disease patients.
    Valli A; Carrero JJ; Qureshi AR; Garibotto G; Bárány P; Axelsson J; Lindholm B; Stenvinkel P; Anderstam B; Suliman ME
    Clin Chim Acta; 2008 Sep; 395(1-2):106-10. PubMed ID: 18565329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of inflammation to vascular disease in chronic kidney disease patients.
    Suliman ME; Stenvinkel P
    Saudi J Kidney Dis Transpl; 2008 May; 19(3):329-45. PubMed ID: 18445891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The renal patient with cardiovascular disease--no longer a simple plumbing problem.
    Tunuguntla A; Yerra L
    Tenn Med; 2005 Aug; 98(8):395-6, 399. PubMed ID: 16315466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inflammation, oxidative stress and kidney function in arterial hypertension].
    Cerasola G; Guarneri M; Cottone S
    G Ital Nefrol; 2009; 26 Suppl 46():8-13. PubMed ID: 19644813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unique character of cardiovascular disease in chronic kidney disease and its implications for treatment with lipid-lowering drugs.
    Nogueira J; Weir M
    Clin J Am Soc Nephrol; 2007 Jul; 2(4):766-85. PubMed ID: 17699494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anemia and cardiovascular risk: the lesson of the CREATE Trial.
    Locatelli F; Del Vecchio L; Pozzoni P
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S262-6. PubMed ID: 17130272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical epidemiology of cardiovascular disease in chronic kidney disease.
    Kundhal K; Lok CE
    Nephron Clin Pract; 2005; 101(2):c47-52. PubMed ID: 15942250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic kidney disease increases cardiovascular mortality in 80-year-old subjects in Japan.
    Kagiyama S; Matsumura K; Ansai T; Soh I; Takata Y; Awano S; Sonoki K; Yoshida A; Takehara T; Iida M
    Hypertens Res; 2008 Nov; 31(11):2053-8. PubMed ID: 19098377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.